novopro retatrutide Retatrutide 20mg | Triple GIP/GLP-1/Glucagon

doi: 10.1007/s00223-018-0507-0

Brand names are used for informational purposes only

When you eat, GLP-1 signals your pancreas to release insulin, lowering blood sugar

The main differences between the two peptides are the following: Development and Approval: Semaglutide was developed later (2010) than liraglutide, and it also received FDA approval much more recently for type 2 diabetes treatment (2017), cardiovascular risk reduction in diabetes (2021) and overweight and obesity management in adults (2021) and adolescents (2023)

Your experience may vary based on age, metabolism, compliance, and underlying conditions

While this might seem counterintuitive since glucagon raises blood glucose, the combined effect with GLP-1 and GIP agonism keeps glucose levels in check while dramatically increasing the metabolic rate